NCT06695143View on ClinicalTrials.gov

Antimicrobial Adjuvants to Revert the Imbalance of Skin Microbiota for Improved Outcomes of Complicated Cutaneous Leishmaniasis Treatment in Ethiopia

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

April 30, 2027

Conditions
Leishmaniasis, Cutaneous
Interventions
DRUG

Fusidic Acid

Fusidic acid 2% cream

OTHER

Vehicle cream

Cetomacrogol cream

Trial Locations (2)

Unknown

Arba Minch General Hospital, Arba Minch

Chencha Primary Hospital, Chencha

All Listed Sponsors
collaborator

Armauer Hansen Research Institute (AHRI), Ethiopia

UNKNOWN

collaborator

Arba Minch University

OTHER

lead

Institute of Tropical Medicine, Belgium

OTHER